Marsh & McLennan [MMC] vs Willis Towers Watson [WTW] Detailed Stock Comparison

Marsh & McLennan
NYSE
Loading...

Willis Towers Watson
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Marsh & McLennan wins in 11 metrics, Willis Towers Watson wins in 9 metrics, with 0 ties. Marsh & McLennan appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Marsh & McLennan | Willis Towers Watson | Better |
---|---|---|---|
P/E Ratio (TTM) | 25.32 | 227.31 | Marsh & McLennan |
Price-to-Book Ratio | 6.58 | 4.06 | Willis Towers Watson |
Debt-to-Equity Ratio | 135.27 | 72.56 | Willis Towers Watson |
PEG Ratio | 3.21 | 1.58 | Willis Towers Watson |
EV/EBITDA | 16.34 | 14.17 | Willis Towers Watson |
Profit Margin (TTM) | 16.00% | 1.40% | Marsh & McLennan |
Operating Margin (TTM) | 26.91% | 16.94% | Marsh & McLennan |
EBITDA Margin (TTM) | 26.91% | 16.94% | Marsh & McLennan |
Return on Equity | 28.41% | 1.67% | Marsh & McLennan |
Return on Assets (TTM) | 7.86% | 4.66% | Marsh & McLennan |
Free Cash Flow (TTM) | $3.99B | $1.27B | Marsh & McLennan |
Dividend Yield | 1.51% | 1.51% | Marsh & McLennan |
1-Year Return | -5.72% | 20.53% | Willis Towers Watson |
Price-to-Sales Ratio (TTM) | 4.02 | 3.35 | Willis Towers Watson |
Enterprise Value | $123.84B | $36.75B | Marsh & McLennan |
EV/Revenue Ratio | 4.80 | 3.75 | Willis Towers Watson |
Gross Profit Margin (TTM) | 44.15% | 35.91% | Marsh & McLennan |
Revenue per Share (TTM) | $52 | $98 | Willis Towers Watson |
Earnings per Share (Diluted) | $8.33 | $1.48 | Marsh & McLennan |
Beta (Stock Volatility) | 0.78 | 0.68 | Willis Towers Watson |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Marsh & McLennan vs Willis Towers Watson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Marsh & McLennan | -0.27% | 1.61% | 0.12% | -7.84% | -9.58% | -0.37% |
Willis Towers Watson | 0.62% | 2.64% | 9.91% | 10.12% | 3.36% | 9.69% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Marsh & McLennan | -5.72% | 26.87% | 84.69% | 288.97% | 778.76% | 680.68% |
Willis Towers Watson | 20.53% | 63.25% | 64.96% | 195.28% | 335.77% | 284.46% |
Performance & Financial Health Analysis: Marsh & McLennan vs Willis Towers Watson
Metric | MMC | WTW |
---|---|---|
Market Information | ||
Market Cap | $103.70B | $32.82B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 2,292,330 | 602,709 |
90 Day Avg. Volume | 2,608,213 | 682,463 |
Last Close | $210.55 | $339.24 |
52 Week Range | $196.27 - $248.00 | $280.86 - $344.14 |
% from 52W High | -15.10% | -1.42% |
All-Time High | $248.00 (Mar 31, 2025) | $344.14 (Mar 03, 2025) |
% from All-Time High | -15.10% | -1.42% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.12% | 0.00% |
Quarterly Earnings Growth | 0.08% | 1.35% |
Financial Health | ||
Profit Margin (TTM) | 0.16% | 0.01% |
Operating Margin (TTM) | 0.27% | 0.17% |
Return on Equity (TTM) | 0.28% | 0.02% |
Debt to Equity (MRQ) | 135.27 | 72.56 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $32.07 | $82.78 |
Cash per Share (MRQ) | $3.41 | $20.41 |
Operating Cash Flow (TTM) | $4.92B | $1.41B |
Levered Free Cash Flow (TTM) | $4.34B | $1.34B |
Dividends | ||
Last 12-Month Dividend Yield | 1.51% | 1.51% |
Last 12-Month Dividend | $3.24 | $4.48 |
Valuation & Enterprise Metrics Analysis: Marsh & McLennan vs Willis Towers Watson
Metric | MMC | WTW |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 25.32 | 227.31 |
Forward P/E | 22.37 | 18.60 |
PEG Ratio | 3.21 | 1.58 |
Price to Sales (TTM) | 4.02 | 3.35 |
Price to Book (MRQ) | 6.58 | 4.06 |
Market Capitalization | ||
Market Capitalization | $103.70B | $32.82B |
Enterprise Value | $123.84B | $36.75B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.80 | 3.75 |
Enterprise to EBITDA | 16.34 | 14.17 |
Risk & Other Metrics | ||
Beta | 0.78 | 0.68 |
Book Value per Share (MRQ) | $32.07 | $82.78 |
Financial Statements Comparison: Marsh & McLennan vs Willis Towers Watson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MMC | WTW |
---|---|---|
Revenue/Sales | $7.06B | $2.22B |
Cost of Goods Sold | $3.85B | $1.32B |
Gross Profit | $3.21B | $899.00M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $2.01B | $432.00M |
EBITDA | $2.29B | $460.00M |
Pre-Tax Income | $1.83B | $303.00M |
Income Tax | $415.00M | $65.00M |
Net Income (Profit) | $1.41B | $239.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MMC | WTW |
---|---|---|
Cash & Equivalents | $1.60B | $1.51B |
Total Current Assets | $22.46B | $15.46B |
Total Current Liabilities | $19.78B | $13.38B |
Long-Term Debt | $20.43B | $5.26B |
Total Shareholders Equity | $14.27B | $8.21B |
Retained Earnings | $25.88B | $51.00M |
Property, Plant & Equipment | $3.91B | $1.15B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MMC | WTW |
---|---|---|
Operating Cash Flow | $1.27B | $-123.00M |
Capital Expenditures | N/A | $-51.00M |
Free Cash Flow | $-677.00M | $-86.00M |
Debt Repayment | $-505.00M | $-1.00M |
Common Stock Repurchase | $-300.00M | $-200.00M |
Short Interest & Institutional Ownership Analysis
Metric | MMC | WTW |
---|---|---|
Shares Short | 5.98M | 2.56M |
Short Ratio | 2.21 | 3.50 |
Short % of Float | 0.01% | 0.03% |
Average Daily Volume (10 Day) | 2,292,330 | 602,709 |
Average Daily Volume (90 Day) | 2,608,213 | 682,463 |
Shares Outstanding | 491.40M | 99.81M |
Float Shares | 490.71M | 97.17M |
% Held by Insiders | 0.00% | 0.00% |
% Held by Institutions | 0.93% | 0.98% |
Dividend Analysis & Yield Comparison: Marsh & McLennan vs Willis Towers Watson
Metric | MMC | WTW |
---|---|---|
Last 12-Month Dividend | $3.24 | $4.48 |
Last 12-Month Dividend Yield | 1.51% | 1.51% |
3-Year Avg Annual Dividend | $2.58 | $3.73 |
3-Year Avg Dividend Yield | 0.36% | 0.34% |
3-Year Total Dividends | $7.73 | $11.18 |
Ex-Dividend Date | Apr 03, 2025 | Jun 30, 2025 |